Kevin T. Conroy - Feb 24, 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Stock symbol
EXAS
Transactions as of
Feb 24, 2025
Transactions value $
-$317,680
Form type
4
Date filed
2/26/2025, 08:00 PM
Previous filing
Feb 21, 2025
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +13.2K +1.19% $0.00 1.12M Feb 25, 2025 Direct F1
transaction EXAS Common Stock Tax liability -$318K -6.2K -0.55% $51.28 1.12M Feb 25, 2025 Direct F2, F3
holding EXAS Common Stock 28.6K Feb 24, 2025 Held in 401(k) Plan
holding EXAS Common Stock 73.3K Feb 24, 2025 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 72.1K Feb 24, 2025 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 24, 2025 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 24, 2025 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 24, 2025 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 102K Feb 24, 2025 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Award $0 +111K $0.00 111K Feb 24, 2025 Common Stock 111K Direct F4, F5
transaction EXAS Restricted Stock Units Options Exercise $0 -13.2K -50% $0.00 13.2K Feb 25, 2025 Common Stock 13.2K Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 1,455,785 shares, Mr. Conroy also holds, in the aggregate, an additional 770,611 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 These restricted stock units vest in four equal annual installments beginning on February 27, 2026.
F6 Represents a restricted stock unit award granted on February 25, 2022 that vests in four equal annual installments from the grant date.